Additionally, these ABC transporters are regulated by several oncogenic pathways such as NF-κB, TGF-β, PI3K/AKT, EGF [120], and Hh [121] to promote drug efflux and consequently chemoresistance in cancer. This evidence concerns the gene ABCG2 and cancer.